• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人斯蒂尔病中的肺实质疾病:疾病严重程度的一个新出现的标志物——来自意大利临床与实验风湿病研究小组(GIRRCS)患者队列的特征及预测因素

Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients.

作者信息

Ruscitti Piero, Berardicurti Onorina, Iacono Daniela, Pantano Ilenia, Liakouli Vasiliki, Caso Francesco, Emmi Giacomo, Grembiale Rosa Daniela, Cantatore Francesco Paolo, Atzeni Fabiola, Perosa Federico, Scarpa Raffaele, Guggino Giuliana, Ciccia Francesco, Barile Antonio, Cipriani Paola, Giacomelli Roberto

机构信息

Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, delta 6 building, PO box 67100, L'Aquila, Italy.

Rheumatology Section, Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

出版信息

Arthritis Res Ther. 2020 Jun 22;22(1):151. doi: 10.1186/s13075-020-02245-5.

DOI:10.1186/s13075-020-02245-5
PMID:32571407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7310010/
Abstract

BACKGROUND

Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder of unknown aetiology usually affecting young adults. Interestingly, recent evidence from the juvenile counterpart of AOSD suggested the emergent high fatality rate of lung disease (LD) in these patients. In this work, we aimed to characterise LD in AOSD, to identify associated clinical features and predictive factors, and to describe long-term outcomes of the disease comparing patients with LD and those without.

METHODS

A retrospective assessment of prospectively followed patients, from January 2001 to December 2019, was provided to describe the rate of LD in AOSD, associated clinical features and predictive factors, and long-term outcomes. Patients with AOSD, who were included in Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort, were assessed.

RESULTS

Out of 147 patients included in GIRRCS cohort, 18 (12.25%) patients were reported to be affected by LD, at the time of diagnosis of AOSD, who were characterised by older age, a higher prevalence of myalgia, of lymph node involvement, of pleuritis, and abdominal pain. Furthermore, patients with LD showed higher values of systemic score and ferritin. Among those clinical variables, older age and systemic score were also independently predictors of LD. Chest CT scans were also obtained, and the most common finding was the peripheral consolidations in 8 (44.4%) patients. Finally, a higher mortality rate, of 38.9%, was registered in patients with LD than others, since it was associated with a significant decreased survival rate.

CONCLUSIONS

The presence of LD could suggest an emergent cause of mortality in AOSD, as observed in juvenile counterpart recognising a further marker of severity and poor prognosis to be careful evaluated. Patients with LD were also characterised by some clinical features, higher values of systemic score and ferritin than the others, identifying a subset of patients mostly burdened by systemic signs and symptoms. Although specific designed future studies are needed to fully elucidate the significance of LD in AOSD, a more accurate evaluation and management of this feature could improve the long-term outcomes of these patients.

摘要

背景

成人斯蒂尔病(AOSD)是一种病因不明的全身性炎症性疾病,通常影响年轻人。有趣的是,最近来自AOSD青少年患者的证据表明,这些患者中肺部疾病(LD)的死亡率急剧上升。在这项研究中,我们旨在描述AOSD中的LD特征,确定相关的临床特征和预测因素,并比较有LD和无LD患者的疾病长期结局。

方法

对2001年1月至2019年12月前瞻性随访的患者进行回顾性评估,以描述AOSD中LD的发生率、相关临床特征和预测因素以及长期结局。对纳入意大利临床与实验风湿病研究组(GIRRCS)队列的AOSD患者进行评估。

结果

在GIRRCS队列纳入的147例患者中,18例(12.25%)在AOSD诊断时被报告患有LD,其特征为年龄较大、肌痛、淋巴结受累、胸膜炎和腹痛的患病率较高。此外,LD患者的全身评分和铁蛋白值更高。在这些临床变量中,年龄较大和全身评分也是LD的独立预测因素。还进行了胸部CT扫描,最常见的发现是8例(44.4%)患者出现外周实变。最后,LD患者的死亡率较高,为38.9%,因为这与生存率显著降低相关。

结论

LD的存在可能提示AOSD中一个新的死亡原因,正如在青少年患者中观察到的那样,这是一个需要仔细评估的严重程度和预后不良的进一步标志。LD患者还具有一些临床特征,全身评分和铁蛋白值高于其他患者,这确定了一组主要受全身症状和体征困扰的患者亚组。尽管需要未来进行专门设计的研究来充分阐明LD在AOSD中的意义,但对这一特征进行更准确的评估和管理可能会改善这些患者的长期结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd63/7310010/2c424c6bfd92/13075_2020_2245_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd63/7310010/188249db0f2a/13075_2020_2245_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd63/7310010/c759f0fac953/13075_2020_2245_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd63/7310010/2c424c6bfd92/13075_2020_2245_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd63/7310010/188249db0f2a/13075_2020_2245_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd63/7310010/c759f0fac953/13075_2020_2245_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd63/7310010/2c424c6bfd92/13075_2020_2245_Fig3_HTML.jpg

相似文献

1
Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients.成人斯蒂尔病中的肺实质疾病:疾病严重程度的一个新出现的标志物——来自意大利临床与实验风湿病研究小组(GIRRCS)患者队列的特征及预测因素
Arthritis Res Ther. 2020 Jun 22;22(1):151. doi: 10.1186/s13075-020-02245-5.
2
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.铁蛋白和 C 反应蛋白是成人斯蒂尔病死亡和巨噬细胞活化综合征的预测生物标志物。对意大利临床和实验风湿病学研究组(GIRRCS)多中心队列的分析。
PLoS One. 2020 Jul 9;15(7):e0235326. doi: 10.1371/journal.pone.0235326. eCollection 2020.
3
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study.吸烟习惯对成人斯蒂尔病预后的影响:一项多中心观察性研究的结果
Clin Rheumatol. 2022 Mar;41(3):641-647. doi: 10.1007/s10067-021-05929-8. Epub 2021 Oct 11.
4
Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort.成人斯蒂尔病患者的巨噬细胞活化综合征:意大利临床和实验风湿病学研究组队列研究的生存率和预测因素分析。
J Rheumatol. 2018 Jun;45(6):864-872. doi: 10.3899/jrheum.170955. Epub 2018 Apr 15.
5
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort.肥胖成人Still 病患者的临床特征。一项大型多中心队列研究的数据。
Joint Bone Spine. 2023 Sep;90(5):105576. doi: 10.1016/j.jbspin.2023.105576. Epub 2023 Apr 18.
6
Adult-onset Still's disease with elderly onset: results from a multicentre study.成人斯蒂尔病老年发病:一项多中心研究结果。
Clin Exp Rheumatol. 2022 Sep;40(8):1517-1525. doi: 10.55563/clinexprheumatol/0215kv. Epub 2022 May 4.
7
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry.系统评分可能识别成人斯蒂尔病的危及生命进展:来自GIRRCS成人斯蒂尔病研究组和AIDA网络成人斯蒂尔病登记处的数据
Arthritis Rheumatol. 2024 Jul;76(7):1141-1152. doi: 10.1002/art.42845. Epub 2024 May 15.
8
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.成人斯蒂尔病中生物制剂使用相关的处方动机和患者特征:多中心“真实世界”队列分析。
Rheumatol Int. 2020 Jan;40(1):107-113. doi: 10.1007/s00296-019-04358-w. Epub 2019 Jul 1.
9
Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry.斯蒂尔病中 4 个患者亚群的推导和验证:GIRRCS AOSD 研究组和 AIDA 网络斯蒂尔疾病登记处的结果。
RMD Open. 2023 Nov;9(4). doi: 10.1136/rmdopen-2023-003419.
10
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.成人斯蒂尔病:通过对三个中心的100例病例进行分析评估预后工具并验证系统评分
BMC Med. 2016 Dec 1;14(1):194. doi: 10.1186/s12916-016-0738-8.

引用本文的文献

1
Worldwide evaluation of Clinical Practice Strategies (CliPS) for lung involvement in Still's disease within the JIR-CliPS network: a COST action.JIR-CliPS网络内关于斯蒂尔病肺部受累的临床实践策略(CliPS)的全球评估:一项欧洲科学与技术合作组织(COST)行动
Rheumatol Adv Pract. 2025 Jul 3;9(3):rkaf073. doi: 10.1093/rap/rkaf073. eCollection 2025.
2
Editorial: Modern treatment of autoinflammatory diseases.社论:自身炎症性疾病的现代治疗
Front Med (Lausanne). 2024 May 16;11:1411940. doi: 10.3389/fmed.2024.1411940. eCollection 2024.
3
Diagnosing and Treating Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease as Part of the Still's Disease Continuum.

本文引用的文献

1
Emergent high fatality lung disease in systemic juvenile arthritis.全身型幼年特发性关节炎中突发的高病死率肺病。
Ann Rheum Dis. 2019 Dec;78(12):1722-1731. doi: 10.1136/annrheumdis-2019-216040. Epub 2019 Sep 27.
2
Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors.系统性幼年特发性关节炎相关肺病:特征和危险因素。
Arthritis Rheumatol. 2019 Nov;71(11):1943-1954. doi: 10.1002/art.41073. Epub 2019 Oct 1.
3
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
将系统性幼年特发性关节炎和成人斯蒂尔病作为斯蒂尔病连续谱的一部分进行诊断和治疗。
Mediterr J Rheumatol. 2024 Mar 30;35(Suppl 1):45-57. doi: 10.31138/mjr.290323.dat. eCollection 2024 Mar.
4
Recent advances and evolving concepts in Still's disease.斯蒂尔病的最新进展和不断发展的概念。
Nat Rev Rheumatol. 2024 Feb;20(2):116-132. doi: 10.1038/s41584-023-01065-6. Epub 2024 Jan 11.
5
Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry.斯蒂尔病中 4 个患者亚群的推导和验证:GIRRCS AOSD 研究组和 AIDA 网络斯蒂尔疾病登记处的结果。
RMD Open. 2023 Nov;9(4). doi: 10.1136/rmdopen-2023-003419.
6
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry.与斯蒂尔病中巨噬细胞活化综合征相关的临床和实验室特征:来自国际 AIDA 网络斯蒂尔病登记处的数据。
Intern Emerg Med. 2023 Nov;18(8):2231-2243. doi: 10.1007/s11739-023-03408-3. Epub 2023 Oct 12.
7
Care pathway analysis and evidence gaps in adult-onset Still's disease: interviews with experts from the UK, France, Italy, and Germany.成人斯蒂尔病的护理路径分析与证据空白:对来自英国、法国、意大利和德国的专家进行的访谈
Front Med (Lausanne). 2023 Sep 12;10:1257413. doi: 10.3389/fmed.2023.1257413. eCollection 2023.
8
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.原发性干燥综合征中的间质性肺疾病和肺损伤:一项系统评价和荟萃分析
J Clin Med. 2023 Mar 29;12(7):2586. doi: 10.3390/jcm12072586.
9
[Adult-onset Still's disease : Diagnosis and treatment according to the new S2e guidelines of the German Society of Rheumatology (DGRh)].[成人斯蒂尔病:根据德国风湿病学会(DGRh)新的S2e指南进行诊断和治疗]
Dermatologie (Heidelb). 2023 Apr;74(4):289-297. doi: 10.1007/s00105-023-05128-3.
10
Diagnosis and treatment of adult-onset Still's disease: a concise summary of the German society of rheumatology S2 guideline.成人斯蒂尔病的诊断与治疗:德国风湿病学会S2指南简明摘要
Z Rheumatol. 2023 Feb;82(Suppl 2):81-92. doi: 10.1007/s00393-022-01294-2. Epub 2022 Dec 15.
成人斯蒂尔病中生物制剂使用相关的处方动机和患者特征:多中心“真实世界”队列分析。
Rheumatol Int. 2020 Jan;40(1):107-113. doi: 10.1007/s00296-019-04358-w. Epub 2019 Jul 1.
4
Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still's Disease.成人斯蒂尔病的自身炎症发病机制和靶向治疗。
Clin Rev Allergy Immunol. 2020 Feb;58(1):71-81. doi: 10.1007/s12016-019-08747-8.
5
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study.成人斯蒂尔病的管理:高剂量皮质类固醇作为诱导临床缓解的一线治疗的有效性。一项观察性研究的结果。
Medicine (Baltimore). 2019 Apr;98(15):e15123. doi: 10.1097/MD.0000000000015123.
6
Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.肽基精氨酸脱亚氨酶 2 和 4 调节 TLR-7 依赖性狼疮中的固有和适应性免疫反应。
JCI Insight. 2018 Dec 6;3(23):124729. doi: 10.1172/jci.insight.124729.
7
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.自身免疫性风湿病生物标志物指南 - 循证分析。
Autoimmun Rev. 2019 Jan;18(1):93-106. doi: 10.1016/j.autrev.2018.08.003. Epub 2018 Nov 5.
8
Pathogenesis of adult onset still's disease: current understanding and new insights.成人Still 病的发病机制:现有认识和新见解。
Expert Rev Clin Immunol. 2018 Nov;14(11):965-976. doi: 10.1080/1744666X.2018.1533403. Epub 2018 Oct 12.
9
Mechanisms, biomarkers and targets for adult-onset Still's disease.成人Still 病的发病机制、生物标志物和靶点。
Nat Rev Rheumatol. 2018 Oct;14(10):603-618. doi: 10.1038/s41584-018-0081-x.
10
A comprehensive review on adult onset Still's disease.成人斯蒂尔病的全面综述。
J Autoimmun. 2018 Sep;93:24-36. doi: 10.1016/j.jaut.2018.07.018. Epub 2018 Aug 1.